Skip to main content
Clinical Trials/NCT06331689
NCT06331689
Completed
Not Applicable

EPIDEMIOLOGY AND ITS RESULTS IN HIP FRACTURES FOLLOWED IN POSTOPERATIVE INTENSIVE CARE

Kutahya Health Sciences University2 sites in 1 country68 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Fracture
Sponsor
Kutahya Health Sciences University
Enrollment
68
Locations
2
Primary Endpoint
mortalite ratio
Status
Completed
Last Updated
last year

Overview

Brief Summary

Type of study: Observational study Goal of this : We conducted a retrospective evaluation of patients with HF who received postoperative ICU, with a focus on 30-day, 90-day and 1-year mortality outcomes.

Participant population/health conditions:Patients over the age of 18 who are hospitalized in the intensive care unit of our hospital after hip fracture operation.

Detailed Description

The proportion of elderly individual aged 65 and over in the global populatin is currently %9 and hip fractures (HFs) are a leading injury in this population worldwide. We conducted a retrospective evaluation of patients with HF who received postoperative ICU, with a focus on 30-day, 90-day and 1-year mortality outcomes.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
July 1, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Kutahya Health Sciences University
Responsible Party
Principal Investigator
Principal Investigator

Emel Yıldız

Assistant Professor

Kutahya Health Sciences University

Eligibility Criteria

Inclusion Criteria

  • Patients with postoperative hip fractures hospitalized in the intensive care unit of our hospital

Exclusion Criteria

  • Patients who do not have a hip fracture operation will not be included.

Outcomes

Primary Outcomes

mortalite ratio

Time Frame: one year

Patients with hip fracture who received postoperative intensive care unit , with a focus on 30-day, 90-day and 1-year mortality outcomes.

Study Sites (2)

Loading locations...

Similar Trials